Actively Recruiting

Age: 19Years +
All Genders
ID04767945

Registry of Adult Consenting Patients Admitted to the Liver Unit With Liver Cirrhosis

Led by F.D. Roosevelt Teaching Hospital with Policlinic Banska Bystrica · Updated on 2022-08-03

2000

Participants Needed

1

Research Sites

464 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are collecting detailed information from adult patients hospitalized with liver cirrhosis at a specialized liver unit. The study aims to track the frequency and types of liver cirrhosis complications, such as decompensation events, and measure mortality rates over one year. This observational registry helps to better understand the clinical course and outcomes of liver cirrhosis in hospitalized adults. Upon hospital admission, consenting adults diagnosed primarily with liver cirrhosis and experiencing a decompensating event are enrolled. Their demographic details, clinical status, laboratory tests, and imaging results are carefully recorded and uploaded to the study database. After discharge, follow-up information is collected when patients return to the same institution, and mortality information is regularly updated from the national death registry. Participants provide informed consent and contribute data during hospitalization and follow-up visits. Researchers monitor clinical changes, frailty status at admission, and survival outcomes at 90 days and one year. The total duration of participation varies depending on follow-up visits and outcomes. This registry supports ongoing observation of liver cirrhosis progression and associated health events in adults.

CONDITIONS

Brief Title

Cirrhosis Registry of Hospitalized Patients

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with liver cirrhosis primarily based on clinical evaluation
  • Hospital admission due to a decompensating liver event
  • Able and willing to provide informed consent
Not Eligible

You will not qualify if you...

  • Declined to give informed consent

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) at hospital admission

Monitoring

Duration - Up to 1 year

Participants who undergo routine care are observed with their demographic, clinical, laboratory, and imaging data collected during hospitalization and follow-up.

Follow-up visits as part of routine care, with data uploaded if visits occur at the hospital

Trial Site Locations

Total: 1 location

1

F.D.Roosevelt Teaching Hospital

Banská Bystrica, Slovakia, 97401

Actively Recruiting

Loading map...

Research Team

L

Lubomir Skladany, MD, PhD

J

Janka Vnencakova, PhD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

Metabolic Tracing of Tumour and T Cells in the Ascites of Ov...

Ovarian Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Assessment of intestinal inflammation via fecal calprotectin for early prediction of adverse outcomes in advanced chronic liver disease.

Tomas Koller, Petra Vrbova, Natalia Kubanek...

https://pubmed.ncbi.nlm.nih.gov/39031494